REG - EnQuest PLC - Transaction in Own Shares

EnquestAnnouncement

01/05/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240501:nRSA6973Ma&default-theme=true

RNS Number : 6973M  EnQuest PLC  01 May 2024

FOR IMMEDIATE RELEASE
 
            1 May 2024

 

ENQUEST PLC ("EnQuest" or "the Company")

TRANSACTIONS IN OWN SHARES

EnQuest PLC (the "Company") announces that, on 30 April 2024, it purchased the
following number of its ordinary shares of 5 pence each (the "Ordinary
Shares") through Merrill Lynch International ("Merrill Lynch"). Such purchase
was effected pursuant to the instructions issued by the Company in accordance
with the share repurchase arrangements entered into with Merrill Lynch, as
announced on 29 April 2024 (the "Programme").

Aggregated information of Ordinary Shares purchased on 30 April 2024 according
to each trading venue:

 Venue                  Weighted average price paid per share (GBp)  Aggregate number of shares purchased  Lowest price paid per share (GBp)  Highest price paid per share (GBp)
 London Stock Exchange  16.16                                        202,545                               16.06                              16.26
 Chi-X                  16.15                                        5,323                                 16.04                              16.26
 BATS                   16.13                                        6,962                                 16.04                              16.22
 Turquoise              16.06                                        97                                    16.06                              16.06
 Total (all venues)     16.16                                        214,927                               16.04                              16.26

 

Since 29 April 2024, the Company has purchased 371,679 Ordinary Shares to be
held in Treasury at a cost (including dealing and associated costs) of
£60,572.49.

It is intended that the first 25 million Ordinary Shares purchased under the
Programme will be held in Treasury for issue in due course to the Company's
Employee Benefit Trust. To the extent permitted by law, and after the initial
25 million Ordinary Shares are purchased, all additional Ordinary Shares
purchased under the Programme will be cancelled.

Following the above transaction, there will be 371,679 Ordinary Shares in
Treasury and 1,915,552,660 Ordinary Shares in issue (excluding Treasury
shares). The total voting rights in the Company will accordingly be
1,915,552,660. This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the Company under the
Disclosure and Transparency Rules.

A full breakdown of the individual trades made by Merrill Lynch on behalf of
the Company as part of the share repurchase programme is attached to this
document.

Attachment:http://www.rns-pdf.londonstockexchange.com/rns/6973M_1-2024-4-30.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/6973M_1-2024-4-30.pdf)

 

LEI: 2138008LJU6WFQWOXJ73

 

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.

 

Enquiries:

 

EnQuest
plc
+44 (0)20 7925 4900

Chris Sawyer, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSBRGDSCGXDGSG